SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ishita Drugs & Industries informs about closure of trading window

01 Jul 2021 Evaluate

Pursuant to provision of SEBI (Prohibition of Insider Trading) Regulations, 2015 and Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons of the Company (`Code'), Ishita Drugs & Industries has informed that trading window for dealing in securities of the Company by Designated Persons stands closed from Thursday,1st July, 2021 till 48 hours after the declaration of the Unaudited Financial Results for the quarter ended 30th June, 2021 to the Stock Exchange.

The above information is a part of company’s filings submitted to BSE.

Ishita Drugs & Inds. Share Price

76.06 -4.64 (-5.75%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×